Skip to main content

Table 5 Utilization of CBD in 428 patients with arthritis based on type of arthritis

From: Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study

  Osteoarthritis Autoimmune arthritis Rheumatoid arthritis  
  N (%) N (%) N (%) P value
Frequency
 <Once/month 10 (4.9) 2 (2.4) 7 (4.9) <.001*
 Monthly 6 (2.9) 1 (1.2) 8 (5.6)  
 Weekly 21 (10.3) 2 (2.4) 19 (13.4)  
 Daily 65 (31.9) 22 (26.8) 47 (33.1)  
 >Once/day 82 (40.2) 29 (35.4) 43 (30.3)  
 Not specified 20 (9.8) 26 (31.7) 18 (12.7)  
Duration
 <1 month 14 (6.9) 4 (4.9) 19 (13.4) .002*
 1–6 months 52 (25.5) 19 (23.2) 26 (18.3)  
 6–12 months 36 (17.6) 15 (18.3) 24 (16.9)  
 1–3 years 49 (24) 19 (23.2) 36 (25.4)  
 >3 years 34 (16.7) 3 (3.7) 17 (12)  
 Not specified 19 (9.3) 22 (26.8) 20 (14.1)  
Daily dose
 ≤25 mg 83 (40.7) 30 (36.6) 64 (45.1) <.001*
 26-75 mg 54 (26.5) 21 (25.6) 30 (21.1)  
 >75mg 49 (24) 4 (4.9) 27 (19)  
 Not specified 18 (8.8) 27 (32.9) 21 (14.8)  
  1. Mg milligrams, % percentage, < = less than, > = greater than, ≤ = less than or equal to
  2. Statistical comparisons performed with Pearson chi-squared test between groups
  3. *Significance determined as P<0.05